NCT00000352CompletedPhase 2
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Locations
- 2
Study Overview
Brief Summary
The purpose of this study is to determine if addition of dextromethorphan to a stable dose of methadone in opioid dependent subjects will significantly affect physical and psychological aspects of opioid tolerance.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Treatment
Eligibility Criteria
- Ages
- 21 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Terminated
Phase 2
Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy ManagementChemotherapy-induced Peripheral NeuropathyNCT02271893University Hospital, Clermont-Ferrand19
Completed
Phase 1
Dextromethorphan Effect on Central Sensitization to Pain in Healthy VolunteersExperimental PainHyperalgesiaNCT02596360University Hospital, Clermont-Ferrand20
Unknown
Phase 3
Combined Therapy of Methadone and DextromethrophanOpioid AbuseNCT01189097National Cheng-Kung University Hospital1,500
Unknown
Not Applicable
Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit PatientsPainOpioid ToleranceAnalgesia ToleranceNCT01553435King Abdullah International Medical Research Center36
Completed
Phase 1
Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use DisorderStimulants Use DisorderNCT03729128Tzu-Yun Wang85